OR WAIT null SECS
November 04, 2021
Gentronix has expanded it lab facilities and increased capacity for genetic, ocular, and skin toxicology testing.
November 03, 2021
Janssen Sciences Ireland was honored for its project execution of a large-scale expansion of biologics drug substance fed-batch capacity.
October 28, 2021
SGS’s new Antwerp, Belgium, clinical research site will house both clinical trial patients and good manufacturing practice drug manufacturing, and its Glasgow, UK, biosafety testing site now has increased testing capacity.
October 15, 2021
MilliporeSigma announced the opening of its second Carlsbad, California-based facility, which doubles production capacity to support commercial and industrial manufacturing of viral vectors.
September 22, 2021
Metrion’s new 12,000 ft² headquarters will significantly expand its range of services and cell lines.
September 14, 2021
AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.
August 26, 2021
Eli Lilly and Company and industry partners, including Ziath, are focused on speeding up the drug discovery process with a fully automated lab.
August 25, 2021
AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
August 18, 2021
BlackBerry’s QNX real-time operating system may create cybersecurity vulnerabilities, according to FDA.